AdipoGen Life Sciences

DR6 (mouse):Fc (human) (rec.)

As low as CHF 170.00
In stock
Only %1 left
AG-40B-0062-C05050 µgCHF 170.00
AG-40B-0062-30503 x 50 µgCHF 340.00

Specifications / Handling

More Information
Product Details
Synonyms Death Receptor 6; Tumor Necrosis Factor Receptor Superfamily Member 21; TNFRSF21
Product Type Protein
Properties
Source/Host HEK 293 cells
Sequence

Mouse DR6 (aa 42-348) is fused at the C-terminus to the Fc portion of human IgG1.

Crossreactivity Mouse
MW ~80kDa (SDS-PAGE)
Purity ≥95% (SDS-PAGE)
Endotoxin Content <0.1EU/μg purified protein (LAL test; Lonza).
Concentration 1mg/ml after reconstitution.
Reconstitution Reconstitute with 50μl sterile water.
Formulation Lyophilized. Contains PBS.
Protein Negative Control

Fc (human) IgG1 Control (rec.)

Other Product Data

UniProt link Q9EPU5: DR6 (mouse)
AfCS Signalling Gateway link: DR6 (mouse)

Shipping and Handling
Shipping BLUE ICE
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice After reconstitution, prepare aliquots and store at -20°C.
Avoid freeze/thaw cycles.
Centrifuge lyophilized vial before opening and reconstitution.
PBS containing at least 0.1% BSA should be used for further dilutions.
Use/Stability Stable for at least 6 months after receipt when stored at -20°C.
Working aliquots are stable for up to 3 months when stored at -20°C.
Documents
Safety Data Sheet Download PDF Download PDF
Product Specification Sheet
Datasheet Download PDF Download PDF

Scientific Background Information

Product Description

DR6 is an orphan TNF receptor superfamily member belonging to a subgroup of receptors called death receptors. Expressed ubiquitously with high expression in lymphoid organs, heart, brain, and pancreas. Broadly expressed by developing neurons where it functions as pro-apoptotic factor. Recently, it has been reported that interaction with the β-amyloid precursor protein (APP) activates a widespread caspase-dependent self-destruction program dependent on caspase-6.

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.